Merck (NYSE:MRK) marked a major milestone in its bid to introduce a new formulation for its famous cancer therapy ...

The phase 3 MK-3475A-D77 trial tested subcutaneous and intravenous Keytruda given every six weeks in combination with ...

On Tuesday, company revealed that its subcutaneous formulation of Keytruda has aced a phase 3 trial, demonstrating ...

Mercury toxicity occurs when the body is exposed to high levels of mercury, a toxic metal. Symptoms can vary depending on the ...

Getting more focused steps into your routine is healthy for your heart, helps you maintain a healthy body weight, and is associated with decreased stress. That said, achieving the popular goal of ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the ...

Your fitness tracker probably tells you how many steps you take most days. And your device likely sets the goal of 10,000 steps a day or maybe that’s what you’ve entered as your daily step ...

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...

Here are the morning's top stories on Tuesday, November 19, 2024… If you’re one of the unlucky people who get bitten by a ...

A senior coroner has warned that more babies could die unless "action is taken", following the deaths of three infants who ...